CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 23 enrolled
Drug / intervention
0.12% chlorhexidine mouthrinse +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01122862
NCT01122862Phase 2Completed

A Clinical Study to Evaluate the Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth

GlaxoSmithKline·interventional·Posted May 13, 2010·Updated Sep 9, 2013

In Brief

A Phase 2 clinical trial evaluating 0.12% chlorhexidine mouthrinse, Cosmetic mouthrinse, and 1 other intervention for Healthy Subjects. Completed, enrolled 23 participants across 1 site.

Detailed Summary

A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 13, 2010
Enrollment StartApr 1, 2010
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.1 years ago

Interventions

0.12% chlorhexidine mouthrinsedrug

commercially available 0.12% chlorhexidine mouthrinse

Cosmetic mouthrinseother

Commerically available cosmetic mouthrinse

Sterile waterother

Sterile water